Nomura Holdings Inc. bought a new position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 57,026 shares of the real estate investment trust's stock, valued at approximately $988,000.
Several other institutional investors have also added to or reduced their stakes in SBRA. VSM Wealth Advisory LLC bought a new stake in shares of Sabra Health Care REIT during the 4th quarter valued at $26,000. Assetmark Inc. increased its holdings in Sabra Health Care REIT by 33.4% in the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock worth $45,000 after purchasing an additional 656 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in Sabra Health Care REIT by 208.3% in the 4th quarter. Jones Financial Companies Lllp now owns 6,222 shares of the real estate investment trust's stock worth $108,000 after purchasing an additional 4,204 shares in the last quarter. FIL Ltd increased its holdings in Sabra Health Care REIT by 40.4% in the 4th quarter. FIL Ltd now owns 6,512 shares of the real estate investment trust's stock worth $113,000 after purchasing an additional 1,873 shares in the last quarter. Finally, Autumn Glory Partners LLC bought a new stake in shares of Sabra Health Care REIT in the 4th quarter valued at about $173,000. 99.40% of the stock is currently owned by institutional investors.
Sabra Health Care REIT Stock Up 2.0%
Shares of SBRA traded up $0.35 during mid-day trading on Friday, reaching $17.44. The company had a trading volume of 2,710,400 shares, compared to its average volume of 2,205,437. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. The firm has a 50-day moving average price of $17.52 and a 200 day moving average price of $17.37. Sabra Health Care REIT, Inc. has a 52 week low of $13.87 and a 52 week high of $20.03. The company has a market capitalization of $4.15 billion, a price-to-earnings ratio of 32.91, a price-to-earnings-growth ratio of 1.97 and a beta of 0.88.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.01. The business had revenue of $183.54 million for the quarter, compared to analysts' expectations of $180.23 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The firm's quarterly revenue was up 10.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.35 EPS. On average, sell-side analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current year.
Sabra Health Care REIT Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 30th. Stockholders of record on Friday, May 16th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, May 16th. This represents a $1.20 annualized dividend and a dividend yield of 6.88%. Sabra Health Care REIT's dividend payout ratio (DPR) is 203.39%.
Insiders Place Their Bets
In other Sabra Health Care REIT news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total transaction of $200,420.00. Following the completion of the transaction, the director now owns 64,725 shares of the company's stock, valued at $1,179,289.50. This represents a 14.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.20% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Several brokerages recently commented on SBRA. Truist Financial upped their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research report on Tuesday, March 18th. Scotiabank upped their target price on Sabra Health Care REIT from $18.00 to $19.00 and gave the company a "sector perform" rating in a research report on Monday, May 12th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.50.
Read Our Latest Stock Analysis on SBRA
Sabra Health Care REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
